Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Unicycive Therapeutics Inc (NASDAQ: UNCY) was $0.76 for the day, up 15.19% from the previous closing price of $0.66. In other words, the price has increased by $15.19 from its previous closing price. On the day, 12.35 million shares were traded.
Ratios:
Our analysis of UNCY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on April 21, 2025, initiated with a Buy rating and assigned the stock a target price of $6.
On April 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Stock Price History:
Over the past 52 weeks, UNCY has reached a high of $0.96, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 27.82%, while the 200-Day Moving Average is calculated to be 38.41%.
Shares Statistics:
A total of 119.75M shares are outstanding, with a floating share count of 100.03M. Insiders hold about 17.08% of the company’s shares, while institutions hold 50.74% stake in the company.
